Advertisement

Biochemistry (Moscow)

, Volume 73, Issue 7, pp 806–811 | Cite as

Engineering, expression, and purification of “soluble” human cytochrome P45017α and its functional characterization

  • T. A. Pechurskaya
  • O. P. Lukashevich
  • A. A. Gilep
  • S. A. UsanovEmail author
Accelerated Publication

Abstract

To engineer a “soluble” form of membrane-bound cytochrome P45017α (CYP17)—a key enzyme in steroid hormone biosynthesis—in the present work we have built a computer model of the tertiary structure of the hemeprotein, identified the surface hydrophobic amino acid residues, substituted these residues for more hydrophilic ones, and expressed and purified hydrophilized forms of CYP17. We have constructed and purified the following mutant forms of human CYP17: CYP17dH (CYP17 with deleted hydrophobic N-terminal sequence (δ23)) and CYP17mod (CYP17dH with substituted cluster of hydrophobic amino acid residues in the region of the FG-loop). Removal of the N-terminal sequence responsible for interaction with the membrane does not dramatically change the association of the protein with the membrane. However, CYP17mod containing hydrophilic FG-loop is mostly localized in the cytosolic fraction. Thus, in the present work we for the first time engineered a “soluble” form of the usually membrane-bound human CYP17 that is not bound to membrane. The expression degree of CYP17mod is approximately 900 nmol/liter of culture. The hemeprotein can be purified to apparent homogeneity without using detergents at any purification step. It is shown that replacement of hydrophobic amino acid residues in the FG-loop region does not change the metabolic profile during hydroxylation of steroids that is characteristic for wild type CYP17. Besides, the modification of the hemeprotein does not affect the affinity of CYP17 to steroid substrates. The engineered “soluble” form of human CYP17 is used as a subject for crystallization of the hemeprotein.

Key words

cytochrome P45017α heterologous expression CYP17 in bacteria “soluble” form of cytochrome P45017α 

Abbreviations

DTT

dithiothreitol

IPTG

isopropyl-β-D-thiogalactopyranoside

OD

optical density

P4

progesterone

P5

pregnenolone

PMSF

phenylmethylsulfonyl fluoride

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Usanov, S. A., Chashchin, V. L., and Akhrem, A. A. (1990) in Molecular Mechanisms of Adrenal Steroidogenesis and Aspects of Regulation and Application, Vol. 3 (Ruckpaul, K., and Rein, H., eds.) Akademie-Verlag, Berlin, pp. 1–57.Google Scholar
  2. 2.
    Nebert, D. W., and Russel, D. W. (2002) Lancet, 360, 1155–1162.PubMedCrossRefGoogle Scholar
  3. 3.
    Lieberman, S., and Warne, P. A. (2001) J. Steroid Biochem. Mol. Biol., 78, 299–312.PubMedCrossRefGoogle Scholar
  4. 4.
    Shet, M. S., Fisher, C. W., Tremblay, Y., Belanger, A., Conley, A. J., Mason, J. I., and Estabrook, R. W. (2007) Drug Metab. Rev., 39, 289–307.PubMedCrossRefGoogle Scholar
  5. 5.
    Gilep, A. A., Estabrook, R. W., and Usanov, S. A. (2004) Biochemistry (Moscow), 69, 364–375.CrossRefGoogle Scholar
  6. 6.
    Qin, K. N., and Rosenfield, R. L. (1998) Mol. Cell. Endocrinol., 145, 111–121.PubMedCrossRefGoogle Scholar
  7. 7.
    Miller, W. L. (2005) Med. Princ. Pract., 14,Suppl. 1, 58–68.PubMedCrossRefGoogle Scholar
  8. 8.
    Auchus, R. J. (2001) Endocrinol. Metab. Clin. North. Am., 30, 101–119.PubMedCrossRefGoogle Scholar
  9. 9.
    Ntais, C., Polycarpou, A., and Ioannidis, J. P. (2003) Cancer Epidemiol. Biomarkers Prev., 12, 120–126.PubMedGoogle Scholar
  10. 10.
    Sakaguchi, M., Mihara, K., and Sato, R. (1984) Proc. Natl. Acad. Sci. USA, 81, 3361–3364.PubMedCrossRefGoogle Scholar
  11. 11.
    Neve, E. P., and Ingelman-Sundberg, M. (1999) FEBS Lett., 460, 309–314.PubMedCrossRefGoogle Scholar
  12. 12.
    Gillam, E. M., Baba, T., Kim, B. R., Ohmori, S., and Guengerich, F. P. (1993) Arch. Biochem. Biophys., 305, 123–131.PubMedCrossRefGoogle Scholar
  13. 13.
    Von Wachenfeldt, C., Richardson, T. H., Cosme, J., and Johnson, E. F. (1997) Arch. Biochem. Biophys., 339, 107–114.CrossRefGoogle Scholar
  14. 14.
    Cosme, J., and Johnson, E. F. (2000) J. Biol. Chem., 275, 2545–2553.PubMedCrossRefGoogle Scholar
  15. 15.
    Sagara, Y., Barnes, H. J., and Waterman, M. R. (1993) Arch. Biochem. Biophys., 304, 272–278.PubMedCrossRefGoogle Scholar
  16. 16.
    De Lemos-Chiarandini, C., Frey, A. B., Sabatini, D. D., and Kreibich, G. (1987) J. Cell Biol., 104, 209–219.PubMedCrossRefGoogle Scholar
  17. 17.
    Graham-Lorence, S., Amarneh, B., White, R. E., Peterson, J. A., and Simpson, E. R. (1995) Protein Sci., 4, 1065–1080.PubMedCrossRefGoogle Scholar
  18. 18.
    Peterson, J. A., and Graham, S. E. (1998) Structure, 6, 1079–1085.PubMedCrossRefGoogle Scholar
  19. 19.
    Gilep, A. A., Guryev, O. L., Usanov, S. A., and Estabrook, R. W. (2001) Biochem. Biophys. Res. Commun., 284, 937–941.PubMedCrossRefGoogle Scholar
  20. 20.
    Omura, T., and Sato, R. (1964) J. Biol. Chem., 239, 2370–2378.PubMedGoogle Scholar
  21. 21.
    Porter, T. D., Wilson, T. E., and Kasper, C. B. (1987) Arch. Biochem. Biophys., 254, 353–367.PubMedCrossRefGoogle Scholar
  22. 22.
    Poulos, T. L., Finzel, B. C., and Howard, A. J. (1987) J. Mol. Biol., 195, 687–700.PubMedCrossRefGoogle Scholar
  23. 23.
    Boddupalli, S. S., Hasemann, C. A., Ravichandran, K. G., Lu, J. Y., Goldsmith, E. J., Deisenhofer, J., and Peterson, J. A. (1992) Proc. Natl. Acad. Sci. USA, 89, 5567–5571.PubMedCrossRefGoogle Scholar
  24. 24.
    Lin, D., Zhang, L. H., Chiao, E., and Miller, W. L. (1994) Mol. Endocrinol., 8, 392–402.PubMedCrossRefGoogle Scholar
  25. 25.
    Auchus, R. J., and Miller, W. L. (1999) Mol. Endocrinol., 13, 1169–1182.PubMedCrossRefGoogle Scholar
  26. 26.
    Qiao, J., Hu, R. M., Peng, Y. D., Song, H. D., Peng, Y. W., Gao, G. F., Hao, J. H., Hu, N. Y., Xu, M. Y., and Chen, J. L. (2003) Mol. Cell Endocrinol., 201, 189–195.PubMedCrossRefGoogle Scholar
  27. 27.
    Sansen, S., Yano, J. K., Reynald, R. L., Schoch, G. A., Griffin, K. J., Stout, C. D., and Johnson, E. F. (2007) J. Biol. Chem., 282, 14348–14355.PubMedCrossRefGoogle Scholar
  28. 28.
    Hahm, J. R., Kim, D. R., Jeong, D. K., Chung, J. H., Lee, M. S., Min, Y. K., Kim, K. W., and Lee, M. K. (2003) Metabolism, 52, 488–492.PubMedCrossRefGoogle Scholar
  29. 29.
    Gupta, M. K., Geller, D. H., and Auchus, R. J. (2001) J. Clin. Endocrinol. Metab., 86, 4416–4423.PubMedCrossRefGoogle Scholar
  30. 30.
    Katagiri, M., Suhara, K., Shiroo, M., and Fujimura, Y. (1982) Biochem. Biophys. Res. Commun., 108, 379–384.PubMedCrossRefGoogle Scholar
  31. 31.
    Akhtar, M. K., Kelly, S. L., and Kaderbhai, M. A. (2005) J. Endocrinol., 187, 267–274.PubMedCrossRefGoogle Scholar

Copyright information

© MAIK Nauka 2008

Authors and Affiliations

  • T. A. Pechurskaya
    • 1
  • O. P. Lukashevich
    • 1
  • A. A. Gilep
    • 1
  • S. A. Usanov
    • 1
    Email author
  1. 1.Institute of Bioorganic ChemistryNational Academy of Sciences of BelarusMinskBelarus

Personalised recommendations